BridgeBio Pharma Inc (BBIO) earnings · rev $502.1M
These earnings events as JSON? API free 100/dayBridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
This BBIO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BBIO revenue for 2025-12-31 was $502.1M. Net income was -$732.9M. Revenue was up 126.3% from 2024-12-31 to 2025-12-31. BBIO currently screens at market cap $13.24B.
When the next BBIO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 126.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BBIO research stays on the stock page; the tape stays on the quote page.
BBIO earnings FAQ
What are BBIO's latest revenue and net income?
Latest cached BridgeBio Pharma Inc (BBIO) revenue for Dec 31, 2025 was $502.1M. Net income was -$732.9M. Statements: https://lician.com/financials/bbio
What is BBIO's latest diluted EPS?
Latest cached BridgeBio Pharma Inc (BBIO) diluted EPS for Dec 31, 2025 was -$3.78.
What period does the latest BBIO earnings print cover?
The latest cached BridgeBio Pharma Inc (BBIO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BBIO revenue change from the prior cached period?
Cached BridgeBio Pharma Inc (BBIO) revenue was up 126.3% from $221.9M (Dec 31, 2024) to $502.1M (Dec 31, 2025). Statements: https://lician.com/financials/bbio
Where are BBIO earnings listed?
Cached earnings facts for BridgeBio Pharma Inc (BBIO) are listed at https://lician.com/earnings/bbio. Statements: https://lician.com/financials/bbio
Not investment advice.